NANOVIRICIDES, INC. NNVC Cash Flow

Nanoviricides, inc. (NNVC)

CashFlow / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	0	0	-9,248	-	-9,397	-11,250	-12,479	-10,724	-9,991	-5,250	-4,356	-2,198	-8,280	-6,706	-6,188	-13,601	-8,781	-13,788	-13,633	-8,875	-8,338	-6,688	-6,871	-6,207	-5,820	-6,335	-6,519	-6,477	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued for license
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Preferred shares issued for license
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Preferred shares issued as compensation
230	234	237	266	320	420	524	614	1,228	1,248	1,272	1,436	900	882	882	1,219	1,057	986	877	2,258	2,217	2,195	2,123	70	508	445	445	793	982	982	982	-784	-53	0	0	0	0	0
Common shares issued as compensation and for services
233	233	282	326	315	315	266	312	328	328	328	399	342	342	345	306	282	282	279	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants granted to Scientific Advisory Board
3	4	5	6	9	12	16	19	20	26	37	45	53	51	42	36	37	46	59	84	101	116	199	202	204	206	141	154	173	195	211	214	217	216	205	0	0	0
Common shares issued as compensation and for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	129	181	177	163	148	264	253	253	1,672	1,806	1,868	1,865	0	0	0
Common shares issued for debenture interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-665	0	0	0	-	-	-	-	-	-	-	-
Common Stock issued upon cashless exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for interest on debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Shares of common stock issued in connection with debenture offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued upon conversion of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for services rendered
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-
Common stock for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Preferred stock issued as compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-
Stock-based compensation expense
0	0	11	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0
Depreciation
690	689	687	685	682	676	671	666	661	657	654	651	651	652	651	629	517	404	294	205	199	201	203	204	211	210	210	210	206	210	210	0	0	0	-	-	-	-
Amortization
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization
-	-	-	-	-	-	-	0	0	8	-	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	13	8	8	0	0	0	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Change in fair value of derivative liability
156	425	179	836	1,186	2,164	2,554	1,969	1,940	2,247	1,696	3,133	560	-932	541	1,149	6,522	6,999	8,529	3,434	5,751	6,000	-1,443	1,005	-4,808	-5,428	-1,249	-910	-481	-426	-172	65	89	-65	-62	0	0	0
Amortization of debt discount convertible debentures
-	-	-	-	-	-	359	582	880	1,183	1,347	1,504	1,570	1,496	1,427	1,361	1,295	1,235	1,175	0	0	0	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Amortization of debt discount convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	419	276	135	0	0	0	0	-	-	-	-	-	-	-	-
Discount on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-	-	-	-
Changes in operating assets and liabilities:
Non cash interest on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Non cash interest expense on beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Prepaid expenses
88	19	29	60	-70	9	50	115	20	-15	-29	-97	113	44	5	5	-129	104	106	-483	-24	-199	56	797	4	366	284	245	478	116	-18	-10	7	44	41	0	0	0
Other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	-167	-209	-209	-209	0	0	0
Deferred expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Other assets
16	18	21	-11	-25	-37	-50	-44	-45	-46	-40	0	0	0	-	-	-	-	142	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses- related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
448	336	86	51	147	229	87	82	-50	-179	39	40	-50	210	7	48	-325	-97	-286	-231	257	-252	113	17	-42	23	24	28	57	286	158	-116	-106	-86	-48	0	0	0
Accounts payable - related party
186	-4	716	-958	-674	-100	-233	1,688	1,442	160	-426	-380	-1,078	-79	451	446	903	831	266	0	0	0	-	-	0	0	-	245	-69	-269	-97	-54	-8	51	-730	0	0	0
Accrued expenses
-86	-169	-184	-299	113	196	219	354	-25	-1	-1	-26	38	16	7	-46	-149	-245	-63	-82	-63	-54	-112	59	153	221	107	96	23	4	69	79	-91	-5	-58	0	0	0
Deferred interest payable
-	-	-	-	-	-	-41	-83	-125	-166	-166	-166	-166	-166	-166	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET CASH USED IN OPERATING ACTIVITIES
-	-	-6,800	-8,650	-7,935	-7,181	-7,775	-5,265	-6,022	-7,229	-7,897	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-4,162	-3,961	-3,735	-4,507	0	0	0
Accrued payroll to officers and related payroll tax expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
NET CASH USED IN OPERATING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,702	-6,210	-6,170	-6,212	-5,912	-5,684	-6,705	-6,333	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
CASH FLOWS FROM INVESTING ACTIVITIES:
Collateral advance for affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	2,000	2,000	1,000	0	0	0	-	-	-	-	-	-	-	-
Purchase of property and equipment
20	40	73	80	206	248	241	271	233	170	164	170	137	167	476	1,620	1,810	6,531	6,760	7,177	8,186	3,519	5,231	3,683	2,422	2,338	64	0	0	0	23	45	69	69	152	0	0	0
NET CASH USED IN INVESTING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-81	-108	-98	-194	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Deferred issuance costs
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of trademark
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	11	29	35	36	47	29	41	0	0	0
NET CASH USED IN INVESTING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,231	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,000	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of Convertible Preferred Series C stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Proceeds from issuance of common stock and warrants in connection with private placements of common stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,602	28,602	9,690	9,690	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,743	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	-	-	-
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Collection of stock subscriptions received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
NET CASH PROVIDED BY FINANCING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34,338	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
NET CASH PROVIDED BY FINANCING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	9,465	7,174	7,035	6,970	0	0	0
NET CHANGE IN CASH AND CASH EQUIVALENTS
-3,196	-5,207	-4,526	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET CHANGE IN CASH AND CASH EQUIVALENTS
-	-	-	-	-	-	-	-	-	-8,400	-	-9,441	-8,936	-7,567	-7,305	-8,323	-7,020	-11,640	-5,229	654	18,309	21,919	22,773	17,807	3,068	6,271	-351	2,473	1,780	2,050	5,050	5,221	3,104	3,201	2,268	0	0	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid
0	0	0	0	0	0	166	-152	13	53	173	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,771	1,470	1,021	980	480	480	725	480	197	197	197	197	0	0	0	0	0	0	0	0	0	0	0
Income tax paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-cash Financing and Investing Activities:
Common stock issued for debenture payment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,152	1,152	1,646	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock warrants granted to scientific advisory board
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-
Stock warrants granted to brokers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-
Debt discount related to beneficial conversion feature of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Stock Warrants issued in connection with Private Placement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-